Scott Kellen, CFO and Secretary at DiaMedica Therapeutics Inc. (DMAC), bought 3,000 shares at $2.43 ($7K) on 2019-08-19, disclosed to the SEC on 2019-08-19.
Open-market purchase of $7k DMAC by CFO and Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| DMAC | BUY | 2020-11-10 | $8K | — | Filing → |
| DMAC | BUY | 2019-05-28 | $12K | — | Filing → |
| DMAC | BUY | 2018-12-11 | $5K | — | Filing → |